US2009053782A1PendingUtilityA1

Yeast cells having disrupted pathway from dihydroxyacetone phosphate to glycerol

Assignee: DUNDON CATHERINE ASLESONPriority: Mar 13, 2006Filed: Mar 13, 2007Published: Feb 26, 2009
Est. expiryMar 13, 2026(expired)· nominal 20-yr term from priority
C12N 15/52B65G 15/12Y02E50/10C12P 7/56Y10T137/85986E01B 29/32C12P 7/40C12P 7/06B65G 17/12
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Yeast cells are genetically modified to disrupt a native metabolic pathway from dihydroxyacetone to glycerol. In certain aspects, the yeast cell is of the genera Kluyueromyces, Candida or Issatchenkia . In other aspects, the yeast cell is capable of producing at least one organic acid, such as lactate. The yeast cells produce significantly less glycerol than the wild-type strains, and usually produce greater yields of desired fermentation products. Yeast cells of the invention often grow well when cultivated, despite their curtailed glycerol production.

Claims

exact text as granted — not AI-modified
1 . A cell of a pre-whole genome duplication hemiascomycetous yeast, which is genetically modified to delete or disrupt a native metabolic pathway from dihydroxyacetone phosphate to glycerol, which cell, when cultivated in the presence of a carbon source that can be metabolized by the cell, metabolizes less than 2% of the weight of carbon source that is consumed by the cell to glycerol. 
     
     
         2 - 4 . (canceled) 
     
     
         5 . The cell of  claim 1  which contains a functional LDH gene cassette, and which produces lactate. 
     
     
         6 . The cell of  claim 5  wherein the deletion or disruption of the native metabolic pathway includes a deletion or disruption of at least one native glycerol-3-phosphate dehydrogenase gene. 
     
     
         7 . The cell of  claim 5  wherein the deletion or disruption of the native metabolic pathway includes a deletion or disruption of at least one native glycerol-3-phosphatase gene. 
     
     
         8 . The cell of  claim 5  wherein the deletion or disruption of the native metabolic pathway includes a deletion or disruption of at least one native glycerol-3-phosphate dehydrogenase gene and of at least one native glycerol-3-phosphatase gene. 
     
     
         9 . The cell of  claim 5  wherein the deletion of disruption of the native metabolic pathway may include a deletion or disruption of at least one native dihydroxyacetone phosphatase gene, a deletion or disruption of a native glycerol dehydrogenase gene, or a deletion or disruption of both a native dihydroxyacetone phosphatase gene and a native glycerol dehydrogenase gene. 
     
     
         10 . The cell of any of claims  4 - 9  which contains a deletion or disruption of a native metabolic pathway from pyruvate to ethanol. 
     
     
         11 . The cell of  claim 1 , which cell is within the  Zygosaccharomyces, Zygotorulaspora, Torulaspora, Lachancea, Kluyveromyces, Eremothecium  or  Hanseniaspora  clades of the  Saccharomyces  complex (Kurtzman 2003) and which, when cultivated in the presence of a carbon source that can be metabolized by the cell, metabolizes less than 2% of the weight of carbon source that is consumed by the cell to glycerol. 
     
     
         12 - 19 . (canceled) 
     
     
         20 . The cell of  claim 1 , which cell is of the genera  Kluyveromyces, Candida  or  Issatchenkia , which is genetically modified to delete or disrupt a native metabolic pathway from dihydroxyacetone phosphate to glycerol and which when cultivated in the presence of a carbon source that can be metabolized by the cell, metabolizes less than 2% of the weight of carbon source that is consumed by the cell to glycerol. 
     
     
         21 - 27 . (canceled) 
     
     
         28 . The cell of  claim 1 , which cell is within the  I. orientalis/P. fermentans  clade (Kurtzman and Robnett 1998) or within the  Kluyveromyces  clade of the  Saccharomyces  complex (Kurtzman 2003), which is genetically modified to delete or disrupt a native metabolic pathway from dihydroxyacetone phosphate to glycerol, and which, when cultivated in the presence of a carbon source that can be metabolized by the cell, metabolizes less than 2% of the weight of carbon source that is consumed by the cell to glycerol. 
     
     
         29 - 30 . (canceled) 
     
     
         31 . The cell of  claim 28  which contains a functional LDH gene cassette, and which produces lactate. 
     
     
         32 - 34 . (canceled) 
     
     
         35 . The cell of  claim 31 , which is a  K. marxianus  cell. 
     
     
         36 . The cell of  claim 35 , which contains a deletion or disruption of a native metabolic pathway from pyruvate to ethanol. 
     
     
         37 . The cell of  claim 31 , which is an  I. orientalis  cell. 
     
     
         38 . The cell of  claim 37 , which contains a deletion or disruption of a native metabolic pathway from pyruvate to ethanol. 
     
     
         39 . A genetically modified cell of a pre-whole genome duplication yeast species, which produces less than 2.0 g/L of glycerol when cultivated under the following standard microaerobic conditions: 
       A. defined aqueous medium containing, at the start of cultivation, 5 g/L ammonium sulfate, 3 g/L potassium dihydrogen phosphate, 0.5 g/L magnesium sulfate, trace elements, vitamins, 150 g/L glucose; 
       B. pH of 3.5 at the start of cultivation, with the fermentation medium being buffered if necessary to prevent the pH from falling below 3.0 or rising above 7.0 during the cultivation; 
       C. Cultivation inoculated with the yeast cell to an OD 600  of 1.0; 
       D. Cultivation temperature 30° C.; 
       E. Cultivation is continued until the glucose concentration is reduced to 10 g/L, but is not continued for longer than 120 hours; 
       F. Aeration and agitation sufficient to produce an oxygen uptake rate of 5.0±1.0 mmol/L/hr. 
     
     
         40 - 44 . (canceled) 
     
     
         45 . A genetically modified cell of a pre-whole genome duplication yeast species, which genetically modified cell lacks the ability to produce an active glycerol-3-phosphate dehydrogenase enzyme that is natively produced by cells of the wild-type yeast species. 
     
     
         46 - 49 . (canceled) 
     
     
         50 . A cell of a pre-whole genome duplication yeast species, which lacks the ability to produce an active glycerol-3-phosphatase enzyme that is natively produced by wild-type cells of the yeast species. 
     
     
         51 - 54 . (canceled) 
     
     
         55 . A yeast cell that is genetically modified to produce a product organic acid, said yeast cell further having a deletion or disruption of a native metabolic pathway from dihydroxyacetone phosphate to glycerol and a deletion or disruption of a native metabolic pathway from pyruvate to ethanol. 
     
     
         56 - 59 . (canceled) 
     
     
         60 . The yeast cell of  claim 55  wherein the organic acid is lactate. 
     
     
         61 . A fermentation process wherein a cell of  claim 1  is cultivated under fermentation conditions and in the presence of a carbon source to produce a desired fermentation product, wherein the glycerol yield is less than 2% based on the weight of the carbon source that is consumed by the cell. 
     
     
         62 - 66 . (canceled) 
     
     
         67 . A fermentation process wherein a cell of  claim 5  is cultivated under fermentation conditions and in the presence of a carbon source to produce lactate, wherein the glycerol yield is less than 2% based on the weight of the carbon source that is consumed by the cell. 
     
     
         68 - 69 . (canceled)

Join the waitlist — get patent alerts

Track US2009053782A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.